Cargando…

Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1

MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Barbara, Gasch, Alexander, Rodriguez, Dayté, Chami, Mohamed, Khan, Muzamil M., Rudolf, Rüdiger, Bibby, Jaclyn, Hanashima, Akira, Bogomolovas, Julijus, von Castelmur, Eleonore, Rigden, Daniel J., Uson, Isabel, Labeit, Siegfried, Mayans, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971405/
https://www.ncbi.nlm.nih.gov/pubmed/24671946
http://dx.doi.org/10.1098/rsob.130172
_version_ 1782309470603313152
author Franke, Barbara
Gasch, Alexander
Rodriguez, Dayté
Chami, Mohamed
Khan, Muzamil M.
Rudolf, Rüdiger
Bibby, Jaclyn
Hanashima, Akira
Bogomolovas, Julijus
von Castelmur, Eleonore
Rigden, Daniel J.
Uson, Isabel
Labeit, Siegfried
Mayans, Olga
author_facet Franke, Barbara
Gasch, Alexander
Rodriguez, Dayté
Chami, Mohamed
Khan, Muzamil M.
Rudolf, Rüdiger
Bibby, Jaclyn
Hanashima, Akira
Bogomolovas, Julijus
von Castelmur, Eleonore
Rigden, Daniel J.
Uson, Isabel
Labeit, Siegfried
Mayans, Olga
author_sort Franke, Barbara
collection PubMed
description MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fold as well as for high-order assembly into functional entities. But data on CC from this family that can clarify the structural significance of this motif are scarce. We have characterized the helical region from MuRF1 and show that, contrary to expectations, its CC domain assembles unproductively, being the B2- and COS-boxes in the fold (respectively flanking the CC) that promote a native quaternary structure. In particular, the C-terminal COS-box seemingly forms an α-hairpin that packs against the CC, influencing its dimerization. This shows that a C-terminal variable domain can be tightly integrated within the conserved TRIM fold to modulate its structure and function. Furthermore, data from transfected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of sarcoskeletal structures and points to the pharmacological relevance of the COS domain for treating MuRF1-mediated muscle atrophy.
format Online
Article
Text
id pubmed-3971405
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-39714052014-04-16 Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1 Franke, Barbara Gasch, Alexander Rodriguez, Dayté Chami, Mohamed Khan, Muzamil M. Rudolf, Rüdiger Bibby, Jaclyn Hanashima, Akira Bogomolovas, Julijus von Castelmur, Eleonore Rigden, Daniel J. Uson, Isabel Labeit, Siegfried Mayans, Olga Open Biol Research MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fold as well as for high-order assembly into functional entities. But data on CC from this family that can clarify the structural significance of this motif are scarce. We have characterized the helical region from MuRF1 and show that, contrary to expectations, its CC domain assembles unproductively, being the B2- and COS-boxes in the fold (respectively flanking the CC) that promote a native quaternary structure. In particular, the C-terminal COS-box seemingly forms an α-hairpin that packs against the CC, influencing its dimerization. This shows that a C-terminal variable domain can be tightly integrated within the conserved TRIM fold to modulate its structure and function. Furthermore, data from transfected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of sarcoskeletal structures and points to the pharmacological relevance of the COS domain for treating MuRF1-mediated muscle atrophy. The Royal Society 2014-03-26 /pmc/articles/PMC3971405/ /pubmed/24671946 http://dx.doi.org/10.1098/rsob.130172 Text en http://creativecommons.org/licenses/by/3.0/ © 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Research
Franke, Barbara
Gasch, Alexander
Rodriguez, Dayté
Chami, Mohamed
Khan, Muzamil M.
Rudolf, Rüdiger
Bibby, Jaclyn
Hanashima, Akira
Bogomolovas, Julijus
von Castelmur, Eleonore
Rigden, Daniel J.
Uson, Isabel
Labeit, Siegfried
Mayans, Olga
Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title_full Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title_fullStr Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title_full_unstemmed Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title_short Molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin MuRF1
title_sort molecular basis for the fold organization and sarcomeric targeting of the muscle atrogin murf1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971405/
https://www.ncbi.nlm.nih.gov/pubmed/24671946
http://dx.doi.org/10.1098/rsob.130172
work_keys_str_mv AT frankebarbara molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT gaschalexander molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT rodriguezdayte molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT chamimohamed molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT khanmuzamilm molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT rudolfrudiger molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT bibbyjaclyn molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT hanashimaakira molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT bogomolovasjulijus molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT voncastelmureleonore molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT rigdendanielj molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT usonisabel molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT labeitsiegfried molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1
AT mayansolga molecularbasisforthefoldorganizationandsarcomerictargetingofthemuscleatroginmurf1